Full name : Gault Laura M
First name : Laura M
Mail : AbbVie Inc., 1 N. Waukegan Road, North Chicago, IL 60064-6123
Zip Code :
City :
Country : USA
Email : laura.gault@abbvie.com
Phone :
Fax :
Website :
Directory :
| Title : Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study - Florian_2016_J.Alzheimers.Dis_51_1237 |
| Author(s) : Florian H , Meier A , Gauthier S , Lipschitz S , Lin Y , Tang Q , Othman AA , Robieson WZ , Gault LM |
| Ref : J Alzheimers Dis , 51 :1237 , 2016 |
| Abstract : Florian_2016_J.Alzheimers.Dis_51_1237 |
| ESTHER : Florian_2016_J.Alzheimers.Dis_51_1237 |
| PubMedSearch : Florian_2016_J.Alzheimers.Dis_51_1237 |
| PubMedID: 26967214 |
| Title : APOE-varepsilon4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease - Waring_2015_J.Alzheimers.Dis_47_137 |
| Author(s) : Waring JF , Tang Q , Robieson WZ , King DP , Das U , Dubow J , Dutta S , Marek GJ , Gault LM |
| Ref : J Alzheimers Dis , 47 :137 , 2015 |
| Abstract : Waring_2015_J.Alzheimers.Dis_47_137 |
| ESTHER : Waring_2015_J.Alzheimers.Dis_47_137 |
| PubMedSearch : Waring_2015_J.Alzheimers.Dis_47_137 |
| PubMedID: 26402762 |
| Title : Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study - Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| Author(s) : Apostol G , Abi-Saab WM , Kratochvil CJ , Adler LA , Robieson WZ , Gault LM , Pritchett YL , Feifel D , Collins MA , Saltarelli MD |
| Ref : Psychopharmacology (Berl) , 219 :715 , 2012 |
| Abstract : Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| ESTHER : Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| PubMedSearch : Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| PubMedID: 21748252 |
| Title : Safety and efficacy of ABT-089 in pediatric attention-deficit\/hyperactivity disorder: results from two randomized placebo-controlled clinical trials - Wilens_2011_J.Am.Acad.Child.Adolesc.Psychiatry_50_73 |
| Author(s) : Wilens TE , Gault LM , Childress A , Kratochvil CJ , Bensman L , Hall CM , Olson E , Robieson WZ , Garimella TS , Abi-Saab WM , Apostol G , Saltarelli MD |
| Ref : J Am Acad Child Adolesc Psychiatry , 50 :73 , 2011 |
| Abstract : Wilens_2011_J.Am.Acad.Child.Adolesc.Psychiatry_50_73 |
| ESTHER : Wilens_2011_J.Am.Acad.Child.Adolesc.Psychiatry_50_73 |
| PubMedSearch : Wilens_2011_J.Am.Acad.Child.Adolesc.Psychiatry_50_73 |
| PubMedID: 21156272 |